IT is reasonable to argue that if one attempts to control the spread of cancer by cytotoxic agents then these should be given by the most appropriate route. Since many cancers spread by the lymphatic pathways it is logical to consider infusing such agents into the lymphatics. In a previous paper (Calnan, Rivero, Fillmore and Mercurius-Taylor, 1967) the permeability of normal lymphatics was studied, and the present work can be considered an extension of this. This study concerns the disposition of two specific cytotoxic agents, methotrexate and cyclophosphamide, when infused into lymphatics.
prevent the normal meta-anaphase step in the process of division of the nuclei of cells.
Folinic acid (5 formyltetrahydrofolic acid) will protect the dividing cell against the effects of methotrexate (Jacobson, 1966) .
The labelled methotrexate has a specific activity of 1x86 me per mg. and a purity greater than 95 %. It has a molecular weight of , and is supplied as the freeze dried sodium salt. Water was added to make the solution required for use and this is stable for about 3 weeks. In practice all our experiments were carried out within 2 weeks.
Cyclophosphamide
Cyclophosphamide is a nitrogen mustard (2-di-2-chloroethylamino-1-oxa-3-aza-2 phosphacylohexane 2-oxide) of molecular weight 261. The 32P-labelled cyclophosphamide had a specific activity of 1 mc per mm and was supplied in 5 ml. propylene glycol. Aliquots of this solution were used in each experiment during a period of two weeks.
Experimental animanl
Adult greyhounds, of mean weight 55 lbs, were used in all experiments because the peripheral lymphatic trunks are large in these dogs and easy to find, the thoracic duct is of fairly constant size and position, and the iliac veins are large enough to accommodate sampling catheters without interference to blood flow.
METHODS
Experimental technique (Fig. 1 (Fig. 2) . If this was not found to be so, adjustments were made to the catheters and a further X-ray taken. These catheters were connected to automatic rapid sampling pipettes (Baird & Tatlock, London) .
A quantity of the labelled agent (methotrexate 0.5 ml.; cyclophosphamide 0-2 ml.) was introduced by hand into the cannula in the paw lymphatic, marked by an air bubble fore and aft, and the constant infusion of saline recontinued. As soon as all the agent had been delivered, samples of blood and lymph were taken. Venous blood samples were collected at 30 second intervals, the final specimen being at 30 minutes. All thoracic duct lymph was collected for 90 minutes in separate pots of 10 minute fractions. All blood and lymph samples were collected in heparinized bottles, and samples for background values were taken before each experiment began.
Venous blood flow was measured by the indicator dilution technique of Shillingford, Bruce and Gabe (1961) , using a special catheter with retrograde injection ports (Kountz, Dempster and Shillingford, 1964) which replaced the normal sampling catheter of the ipsilateral common iliac vein.
Method of counting tritium in plasma (i.e. methotrexate)
Samples of blood and thoracic duct lymph collected in the heparinized tubes were spun to obtain plasma. From each, 1 ml. of plasma was pipetted off and transferred to special clean glass bottles containing 10 ml. of Bray scintillation fluid, when an immediate precipitate of protein was formed. The bottles were stoppered and shaken vigorously for about 5 seconds, and left to stand for at least 3 hours to allow the precipitate to settle. The bottles were then placed in an automatic tri-carb liquid scintillation counter, housed in a deep freeze to attain the working temperature of -8°C. The optimum counting conditions for tritium in this scintillation fluid were found by repeatedly counting the standard reference solution at different voltages. The standard solution was made from 1 ml. of a known dilution of the original tritium in 10 ml. of scintillation fluid.
All bottles were counted for 3 minutes. In some experiments bottles were counted for 10 minutes each, but with no material advantage. The values recorded were corrected to unit time for the volume of each sample.
Method of counting 32P in whole blood (i.e. cyclophosphamide) Since 32P emits some gamma rays, 3 ml. samples of blood or lymph were counted for 100 seconds in a conventional well-type scintillation counter with a sodium iodide crystal.
Experimental design
When a substance, labelled by a radioactive isotope, is placed within a lymphatic trunk and propelled centrally by a constant infusion of saline, then one of two things may happen.
If the substance does not leak out from the lymphatic then one may expect to recover it from the cannulated thoracic duct and no radioactivity will be found in the blood. In this event we may conclude that the lymphatic is impermeable to the passage through its wall of the test substance. If, however, the substance does leak through the lymphatic wall, we may recover a portion of it from the thoracic duct lymph, but we shall also expect to find radioactivity in the blood from the ipsilateral venous samples due to reabsorption by veins. If the shunt of radioactivity from lymphatic to vein is large then there will be a rise in activity of 
RESULTS

Methotrexate
In 3 dogs where methotrexate was infused into a paw lymphatic it was recovered in fair quantity from venous blood: a high proportion of this was found within a few minutes of infusion (Fig. 3) . In 1 dog in which the lymphatics were IU all ligated at the groin, methotrexate was recovered from venous blood with equal speed, but the amount found in thoracic duct lymph was appreciably smaller (Table I) . In a further experiment, methotrexate was infused into the ipsilateral femoral artery, and as expected the amount found in the femoral vein was large and immediate. But the total amount recovered was less than 18 % suggesting that a great deal had become fixed in the tissues (Fig. 4 Although the popliteal lymph node demonstrated the presence of the X-ray contrast medium (Fig. 6) FIa. 7.-Graph of recovery of cyclophosphamide after intra-arterial infusion.
activity. Biopsies of skin from the popliteal region always showed significant radioactivity although the percentage of the total infused was always very small (Table IV) . Because methotrexate was labelled with the isotope tritium, a pure betaemitter, it was not possible technically to show its disposition in tissues. For this reason the work was repeated with cyclophosphamide labelled by 32p. But the results of the latter were almost identical and the proportion in various tissues was small and similar. Moreover when cyclophosphamide in propylene glycol was emulsified with poppy seed oil, the recovery of clyclophosphamide from blood was as great as when infused alone, even though all the poppy seed oil was confined to the popliteal node (Fig. 6) .
In previous studies we have demonstrated that lymphatic permeability depends on molecular size, in that substances of size smaller than 17,000 are freely permeable while those of 21,000 and over are not (Calnan, Rivero, Fillmore and Mercurius-Taylor, 1967) . Since all cytotoxic agents are of relatively small molecular size in comparison, it is not surprising that they leave lymphatics so freely. From the evidence of our experiments it is clear that cytotoxic drugs given intralymphatically cannot offer any special advantage in the treatment of malignant disease.
This form of therapy may have a rational basis if cytotoxic drugs of much larger molecular size can be found or their polymers prepared. Alternatively a drug of smaller molecular size may be bound chemically or physically to a substance of large molecular size in the hope that this bond will break down when the agent reaches the site of the required effect. SUMMARY 1. Methotrexate and cyclophosphamide, labelled with radioactive isotopes, were infused into a lymphatic on the hindpaw of 8 dogs. In 2 dogs these agents were placed in the regional artery. Radioactivity was measured in samples of blood and lymph.
2. Both drugs were found to diffuse freely from the lymphatic trunks.
